Oncology Venture A/S operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Oncology Venture A/S with three other
miscellaneous service companies in Europe:
sales of 3.00 million Polish New Zlotys [US$783,391.13 ]
Plant Advanced Technologies PAT SA
(806,780.00 Euro [US$912,645.67 ]
Shield Therapeutics PLC
based in the United Kingdom
(£637,000.00 [US$822,997.63 ]
of which 100%
During the year ended December of 2017, sales at
Oncology Venture A/S were 5.15 million Danish Kroner (US$779.88 thousand).
increase of 3.1%
versus 2016, when the company's sales were 4.99 million Danish Kroner.
Despite this increase, sales are still
below the level achieved in 2015, when Oncology Venture A/S
reported sales of 5.84 million Danish Kroner.